VISTAGEN THERAPEUTICS, INC. (VTGN) Revenue 2017–2026
VISTAGEN THERAPEUTICS, INC. (VTGN) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.3MFY2026 · since FY2017: $1.3M → $1.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $1.3M | +161.1% |
| FY2025 | $486,000 | -54.3% |
| FY2024 | $1.1M | +568.7% |
| FY2023 | -$227,000 | -120.5% |
| FY2022 | $1.1M | +1.8% |
| FY2021 | $1.1M | — |
| FY2020 | $0 | — |
| FY2018 | $0 | -100.0% |
| FY2017 | $1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice